48,454
edits
Difference between revisions of "Secretory carcinoma of the breast"
Jump to navigation
Jump to search
Secretory carcinoma of the breast (view source)
Revision as of 15:16, 31 December 2019
, 15:16, 31 December 2019→See also
| (3 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
| IHC = ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve | | IHC = ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = ETV6-[[NTRK3]] | ||
| IF = | | IF = | ||
| Gross = | | Gross = | ||
| Grossing = [[ | | Grossing = [[breast grossing]] | ||
| Staging = [[breast cancer staging]] | | Staging = [[breast cancer staging]] | ||
| Site = [[breast]] - see ''[[invasive breast cancer]]'' | | Site = [[breast]] - see ''[[invasive breast cancer]]'' | ||
| Line 64: | Line 64: | ||
Characteristic translocation:<ref name=pmid22129193/> | Characteristic translocation:<ref name=pmid22129193/> | ||
*t(12;15). | *t(12;15). | ||
**ETV6-NTRK3. | **ETV6-[[NTRK3]]. | ||
Note: | Note: | ||
| Line 71: | Line 71: | ||
==See also== | ==See also== | ||
*[[Invasive breast cancer]]. | *[[Invasive breast cancer]]. | ||
*[[ | *[[Secretory carcinoma of the salivary gland]] (previously known as ''mammary analogue secretory carcinoma''). | ||
*[[Congenital-infantile fibrosarcoma]]. | *[[Congenital-infantile fibrosarcoma]]. | ||